NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Secondary Data Analysis of Patients at Risk for CKD to Inspect CKD Prevalence, Diagnosis Rates, Diagnostic Behaviour, Treatment Patterns and Patient Characteristics

NCT05953701

CompletedN/A

Sponsor: AstraZeneca

Conditions: Chronic Kidney Diseases

Countries: Germany

This study is a national secondary data analysis to determine the prevalence of diagnosed and undiagnosed CKD in German primary care offices in a patient population at high risk for the development and progression of CKD. Furthermore, it addresses the question of how CKD screening, monitoring and treatment of these patients is conducted within the German primary care setting.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

1. Age ≥ 18 years at start of the patient´s observation period
2. Having at least one of the following diseases (based on the documented ICD-10 code):

   * Type 1 diabetes
   * Type 2 diabetes
   * Hypertension
   * Cardiovascular disease, including:

     1. Coronary and/or other atherosclerosis
     2. Myocardial infarction
     3. Heart failure
     4. Peripheral arterial disease
     5. Arrythmia
     6. Stroke
3. Having at least one year (52 weeks) of observation period

Exclusion Criteria: NA

Locations (1)

Koblenz, Germany